Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Azurrx Biopharma Inc (AZRX)

2.79 -0.1 (-3.46%)

02-22 15:59

Open:

2.92

Pre. Close:

2.89

High:

2.929

Low:

2.78

Volume:

37,416

Market Cap:

32M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.938 - 2.955

2.955 - 2.968

Low:

2.731 - 2.753

2.753 - 2.772

Close:

2.777 - 2.81

2.81 - 2.837

Technical analysis  (as of: 2018-02-22 5:00:23 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 3.95     One year: 4.39

Support:

Support1: 2.78    Support2: 2.31

Resistance:

Resistance1: 3.39    Resistance2: 3.76

Pivot:

3.03

Moving Averages:

MA(5): 2.90     MA(20): 3.09

MA(100): 3.22     MA(250): 3.63

MACD:

MACD(12,26): -0.12     Signal(12,26,9): -0.09

%K %D:

%K(14,3): 7.30     %D(3): 11.39

RSI:

RSI(14): 36.42

52-Week:

High: 5.25  Low: 2.4  Change(%): -32.9

Average Vol(K):

3-Month: 5018  10-Days 3474

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
AZRX has closed above bottom band by 6.5%. Bollinger Bands are 40.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to AZRX's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 08 Feb 2018 21:22:30 GMT
AzurRx BioPharma to Present at the 2018 BIO CEO & Investor Conference ...

Wed, 27 Sep 2017 12:22:30 GMT
AzurRx BioPharma and Mayoly-Spindler Announce Positive MS1819-SD Phase II Data ...

Thu, 22 Feb 2018 19:52:30 GMT
What's in Azurrx Biopharma Inc (NASDAQ:AZRX) After Decline in Shorted Shares?

Thu, 08 Jun 2017 12:00:00 GMT
AzurRx BioPharma Announces Closing of $5.0 Million Private Financing

Wed, 12 Oct 2016 12:00:00 GMT
AzurRx BioPharma Announces Pricing of Initial Public Offering

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Pharmaceuticals

Shares Out. (M)

11.61

Shares Float (M)

11.12

% Held by Insiders

% Held by Institutions

22.20

Shares Short (K)

11

Shares Short Prior Month (K)

26

Stock Financials

EPS

-0.570

EPS Est. Current Year

-0.850

EPS Est. Next Year

-0.670

EPS Est. Next Quarter

-0.160

Forward EPS

-0.811

Book Value (p.s.)

12.300

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-224.9

Return on Equity (ttm)

281.5

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.749

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.73

Levered Free Cash Flow (M)

-8.89

atoplab.com

Valuation

P/E

-4.93

P/E Growth Ratio

-0.03

P/BV

0.23

P/S

P/CF

-4.85

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.